GENE - Dead pump bouncing, potential buy although ideally wait for more spiking to get short.
REFR - Lincoln just announced they're using REFR's electronic dimming glass tech on their new Continental concept that due to be released next year. This is big news for REFR as Lincoln mentioned the tech in their own PR, potential buy.
GMAN is up on earnings yet earnings is going down each year with
this year being down significantly. Co has 7M cash and 41M in debt.
Technically the chart has a tonne of overhead resistance, potential short
GBSN is a 14M company and recent IPO. Stock up on a video
conference, transcript basically read like a hyped up PR with tonnes of
forward looking statement. Co admitted their stock "awareness" is of
high priority and also did a financing on the 6th of March. Stock is also being pumped by a number of newsletters/Twitter Furus. Price action and volume was snooze worthy yesterday, still a potential short.
ORMP is a paid pump by http://tickerresearch.com. Potential short ideally once 6 cracks.
ADXS, CORT are biotech stocks spiking. ADXS is stuck in a channel
between 12 & 14. Both are potential short. If ADXS can break 14.5
it's a potential b/o buy as shorts are likely to get squeezed.
Tuesday, March 31, 2015
Monday, March 30, 2015
Watch List 30-03-15
MVIS is spiking due to a contact for 14M worth of components
for a
fortune 100 company. Co just received 8M as a licensing fee as part
of the contract. Price has broken above multi-year resistance of
$3.5 and is now fading off as per the overall market.
Potential BUY
GBSN is a 14M company and recent IPO. Stock up on a video conference, transcript basically read like a hyped up PR with tonnes of forward looking statement. Co admitted their stock "awareness" is of high priority and also did a financing on the 6th of March. Potential SHORT.
HQCL is up on news they've opened a credit facility with Wells Fargo. Tonnes of overhead resistance, market cap is unknown, key stats don't add up, seems sketchy...Potential SHORT
GMAN is up on earnings yet earnings is going down each year with this year being down significantly. Co has 7M cash and 41M in debt. Technically the chart has a tonne of overhead resistance, potential SHORT.
ORMP is a paid pump by http://tickerresearch.com. Potential SHORT ideally once 6 cracks.
ADXS, CORT are biotech stocks spiking. ADXS is stuck in a channel between 12 & 14. Both are potential SHORTS. If ADXS can break 14.5 it's a potential b/o BUY as shorts are likely to get squeezed.
JUST WATCHING...
NVGN - Up on positive cancer treatment news......Interesting to see how this one plays out. Historically stock has never held it's gains.
GBSN is a 14M company and recent IPO. Stock up on a video conference, transcript basically read like a hyped up PR with tonnes of forward looking statement. Co admitted their stock "awareness" is of high priority and also did a financing on the 6th of March. Potential SHORT.
HQCL is up on news they've opened a credit facility with Wells Fargo. Tonnes of overhead resistance, market cap is unknown, key stats don't add up, seems sketchy...Potential SHORT
GMAN is up on earnings yet earnings is going down each year with this year being down significantly. Co has 7M cash and 41M in debt. Technically the chart has a tonne of overhead resistance, potential SHORT.
ORMP is a paid pump by http://tickerresearch.com. Potential SHORT ideally once 6 cracks.
ADXS, CORT are biotech stocks spiking. ADXS is stuck in a channel between 12 & 14. Both are potential SHORTS. If ADXS can break 14.5 it's a potential b/o BUY as shorts are likely to get squeezed.
JUST WATCHING...
NVGN - Up on positive cancer treatment news......Interesting to see how this one plays out. Historically stock has never held it's gains.
Thursday, March 26, 2015
Watch List 26-03-15
MVIS is spiking due to a contact for 14M worth of components for a
fortune 100 company. Price has broken above multi-year resistance of
$3.5 and is now fading off.
Potential dip buy at the 3.4 level.
RADA a 24M Co just won a contract with a 64B company, Lockhead Martin. Price is now fading. Potential dip buy at the 2.5 level IF it holds as support.
SEED says China is ready to make another bid for the Co. Last year a state-backed Hunan Xindaxin Co offered 60M for SEED but the execs rejected it in November. Until this "acquisition" news is confirmed it's just hype to me. Potential short.
GMAN has been in a downtrend for the last 4+ years. Revenue is 650M, yet they only have 7M in the cash, makes no sense. Current spike seems to have been fueled by recent earnings, at some point long term investors are probably going to try cut their losses into this spike. Potential short.
ORMP is a paid pump by http://tickerresearch.com. 1st red day yesterday, Potential short ideally into a morning spike.
ADXS, CORT are biotech stocks spiking. All are potential shorts
RADA a 24M Co just won a contract with a 64B company, Lockhead Martin. Price is now fading. Potential dip buy at the 2.5 level IF it holds as support.
SEED says China is ready to make another bid for the Co. Last year a state-backed Hunan Xindaxin Co offered 60M for SEED but the execs rejected it in November. Until this "acquisition" news is confirmed it's just hype to me. Potential short.
GMAN has been in a downtrend for the last 4+ years. Revenue is 650M, yet they only have 7M in the cash, makes no sense. Current spike seems to have been fueled by recent earnings, at some point long term investors are probably going to try cut their losses into this spike. Potential short.
ORMP is a paid pump by http://tickerresearch.com. 1st red day yesterday, Potential short ideally into a morning spike.
ADXS, CORT are biotech stocks spiking. All are potential shorts
Wednesday, March 25, 2015
Watch List 25-03-15
ORMP is a paid pump by http://tickerresearch.com. Potential short
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and is now consolidating/basing around $3.75. Potential buy.
RADA a 24M Co just won a contract with a 64B company, Lockhead Martin. Price is consolidating/basing around $2.75. Potential buy.
SEED says China is ready to make another bid for the Co. Last year a state-backed Hunan Xindaxin Co offered 60M for SEED (36M Market Cap) but the execs rejected it in November. Until this "acquisition" news is confirmed it's just hype to me. 1st red day yesterday after a 1 day spike, like to see a pop outta the gate to get short into. Potential short.
NXTD -Up on 2 PR's about thir Electronc Smart Wallet, The "Wocket". In their YouTube video they've conveniently put their ticker symbol at the end of the clip. Price has started to fade off volume is dropping, $3.25 looks like a key breakdown point.
ADXS, ARQL & CORT All are biotech stocks spiking. All are potential shorts
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and is now consolidating/basing around $3.75. Potential buy.
RADA a 24M Co just won a contract with a 64B company, Lockhead Martin. Price is consolidating/basing around $2.75. Potential buy.
SEED says China is ready to make another bid for the Co. Last year a state-backed Hunan Xindaxin Co offered 60M for SEED (36M Market Cap) but the execs rejected it in November. Until this "acquisition" news is confirmed it's just hype to me. 1st red day yesterday after a 1 day spike, like to see a pop outta the gate to get short into. Potential short.
NXTD -Up on 2 PR's about thir Electronc Smart Wallet, The "Wocket". In their YouTube video they've conveniently put their ticker symbol at the end of the clip. Price has started to fade off volume is dropping, $3.25 looks like a key breakdown point.
ADXS, ARQL & CORT All are biotech stocks spiking. All are potential shorts
Tuesday, March 24, 2015
Watch List 24-03-15
MVIS is spiking due to a contact for 14M worth of components for a
fortune 100 company. Price has broken above multi year resistance of
$3.5 and is now consolidating.
Potential buy.
RADA a 24M Co just won a contract with a 64B company, Lockhead Martin. Stock has a history of having a big day then a fade off. Potential buy.
SEED says China is ready to make another bid for the Co. Last year a state-backed Hunan Xindaxin Co offered 60M for SEED (36M Market Cap) but the execs rejected it in November. Until this "acquisition" news is confirmed it's just hype to me. Potential short.
NXTD -Up on 2 PR's about thir Electronc Smart Wallet, The "Wocket". Problem is smartphone companies already have successful tech out and in their YouTube video they've conveniently put their ticker symbol at the end of the clip....1st red day yesterday, ideally price spikes in the morning to get short into.
ADXS, AMRN, ARQL, CRMD, CORT All are biotech stocks spiking. all are potential shorts. ADXS is nearing a breakout point.
RADA a 24M Co just won a contract with a 64B company, Lockhead Martin. Stock has a history of having a big day then a fade off. Potential buy.
SEED says China is ready to make another bid for the Co. Last year a state-backed Hunan Xindaxin Co offered 60M for SEED (36M Market Cap) but the execs rejected it in November. Until this "acquisition" news is confirmed it's just hype to me. Potential short.
NXTD -Up on 2 PR's about thir Electronc Smart Wallet, The "Wocket". Problem is smartphone companies already have successful tech out and in their YouTube video they've conveniently put their ticker symbol at the end of the clip....1st red day yesterday, ideally price spikes in the morning to get short into.
ADXS, AMRN, ARQL, CRMD, CORT All are biotech stocks spiking. all are potential shorts. ADXS is nearing a breakout point.
Monday, March 23, 2015
Watch List 23-3-15
ENVI - Nice multimonth breakout above $1.6 and $1.80 on earnings. Price gapped up but fizzled off most of the day. Potential buy on breakouts only as stock has lots of overhead resistance.
NXTD -Up on 2 PR's about thir Electronc Smart Wallet, The "Wocket". Problem is smartphone companies already have successful tech out and in their YouTube video they've conveniently put their ticker symbol at the end of the clip....Potential Short.
HIIQ up on earnings, price just broke out above 8 but volume has dropped off. Potential buy if volume comes back.
TLYS up on earnings, price keeps breaking out to new highs. Potential buy
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and is now consolidating. Potential buy.
ANTH biotech stock spiking. Potential short when/if $4 cracks
ARQL biotech stock spiking. Stock in bounce stage of pump and approaching approaching the high. Potential short.
AMPE biotech stock spiking. Stock is holding trend with higher lows over the past 9 days. Stock has been in a 8.25-8.50 channel the past 2 days. Like to see the trend break and short the when price breaks the day low. Potential short.
NXTD -Up on 2 PR's about thir Electronc Smart Wallet, The "Wocket". Problem is smartphone companies already have successful tech out and in their YouTube video they've conveniently put their ticker symbol at the end of the clip....Potential Short.
HIIQ up on earnings, price just broke out above 8 but volume has dropped off. Potential buy if volume comes back.
TLYS up on earnings, price keeps breaking out to new highs. Potential buy
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and is now consolidating. Potential buy.
ANTH biotech stock spiking. Potential short when/if $4 cracks
ARQL biotech stock spiking. Stock in bounce stage of pump and approaching approaching the high. Potential short.
AMPE biotech stock spiking. Stock is holding trend with higher lows over the past 9 days. Stock has been in a 8.25-8.50 channel the past 2 days. Like to see the trend break and short the when price breaks the day low. Potential short.
Friday, March 20, 2015
Watch List 20-3-15
HIIQ up on earnings, price just broke out above 8. Potential buy
TLYS up on earnings, price just broke out to new highs. Potential buy
BDE price spiked from 7 to as high as 10.75 before pulling back and is now consolidating. Stock has broken out above multimonth resistance of 9.5 on earnings and analyst upgrade. 11% short float. Potential dip buy if $9.5 holds
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and is now consolidating. Potential buy.
ANTH biotech stock spiking. Potential short when/if $4 cracks
ARQL biotech stock spiking. Stock in bounce stage of pump and approaching approaching the high. Potential breakout buy
AMPE biotech stock spiking. Stock is holding trend with higher lows over the past 8 days. Like to see the trend break and short the when price breaks the day low. Potential short.
AST biotech stock spiking. Stock has just broken trend on the 10 day chart. Potential short
TLYS up on earnings, price just broke out to new highs. Potential buy
BDE price spiked from 7 to as high as 10.75 before pulling back and is now consolidating. Stock has broken out above multimonth resistance of 9.5 on earnings and analyst upgrade. 11% short float. Potential dip buy if $9.5 holds
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and is now consolidating. Potential buy.
ANTH biotech stock spiking. Potential short when/if $4 cracks
ARQL biotech stock spiking. Stock in bounce stage of pump and approaching approaching the high. Potential breakout buy
AMPE biotech stock spiking. Stock is holding trend with higher lows over the past 8 days. Like to see the trend break and short the when price breaks the day low. Potential short.
AST biotech stock spiking. Stock has just broken trend on the 10 day chart. Potential short
Thursday, March 19, 2015
Watch List 19-03-15
BDE price spiked from 7 to as high as 10.75 before pulling back and closing at 10.36. Stock has broken out above multimonth
resistance of 9.5 on earnings and analyst upgrade. 11% short float.
Ideally like to see some consolidation before price breaks out again as it's made a pretty decent move already and buyers are likely to become sellers at some point. Potential buy.
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and closed at 3.99. Stock has had 3 solid days now, profit taking should happen soon. Potential buy.
RMGN Recent earnings PR win, actual earnings today. If stock shows up on % Gainers it's a potential buy.
ANTH biotech stock spiking. Stock faded all day all day. Potential short.
ARQL biotech stock spiking. Stock in bounce stage of pump with a 2 day resistance of 2.32. Could be the potential top of the bounce. Potential short.
AMPE biotech stock spiking. Stock is holding trend although had a fake breakout today and faded all afternoon. Like to see the trend break and short the when price breaks the day low. Potential short.
AST biotech stock spiking. Stock is consolidating but is still holding trend on the 10 day chart. Potential short
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price has broken above multi year resistance of $3.5 and closed at 3.99. Stock has had 3 solid days now, profit taking should happen soon. Potential buy.
RMGN Recent earnings PR win, actual earnings today. If stock shows up on % Gainers it's a potential buy.
ANTH biotech stock spiking. Stock faded all day all day. Potential short.
ARQL biotech stock spiking. Stock in bounce stage of pump with a 2 day resistance of 2.32. Could be the potential top of the bounce. Potential short.
AMPE biotech stock spiking. Stock is holding trend although had a fake breakout today and faded all afternoon. Like to see the trend break and short the when price breaks the day low. Potential short.
AST biotech stock spiking. Stock is consolidating but is still holding trend on the 10 day chart. Potential short
Wednesday, March 18, 2015
Watch List 18-03-15
BDE price spiked from 7 to 9.64, breaking out above multimonth resistance of 9.5 on earnings and analyst upgrade. 11% short float. Potential buy
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price closed above multiyear resistance of 3.50. Potential buy if the the breakout holds.
REPH up 300% on product & facility acquisition news. Very low float of 806K shares, potential short. Market cap increased from 20M to 60M. Potential short.
RMGN Recent earnings PR win, actual earnings on the 19th. Maybe a buy the rumor sell the news day.
MELA Up on recent news of "new codes" added, don't really understand the significance of this...Seems insignificant, Potential short when/if $3 cracks
ANTH, ARQL, AXN, AMPE, AST are the latest biotech pumps in varying stages of their pumps.
MVIS is spiking due to a contact for 14M worth of components for a fortune 100 company. Price closed above multiyear resistance of 3.50. Potential buy if the the breakout holds.
REPH up 300% on product & facility acquisition news. Very low float of 806K shares, potential short. Market cap increased from 20M to 60M. Potential short.
RMGN Recent earnings PR win, actual earnings on the 19th. Maybe a buy the rumor sell the news day.
MELA Up on recent news of "new codes" added, don't really understand the significance of this...Seems insignificant, Potential short when/if $3 cracks
ANTH, ARQL, AXN, AMPE, AST are the latest biotech pumps in varying stages of their pumps.
Tuesday, March 17, 2015
Watch List 17-03-15
STRL is an earnings winner spiking from 3-3.91 with a strong move in the last hour. Stock is in a downtrend, bagholders likely to be resistance. Potential buy
MVIS company just secured a 14M contract to supply components to a "Fortune 100 Company". Potential buy.
REPH, Biotech spiking on product & facility acquisition news, very low float of 860k shares. Potential short but only on perfect setup.
MELA up on some insignificant news about new designated codes, stock ran from 3.20 to 3.60 into the close on no new news. Seems a bit sketchy. Potential short only after it spikes some more as it only has a 20M market cap
CYTX Just did a $40M dilution financing. Co loves diluting shareholders, every year the no of shares outstanding increases. The last 12 months increased by 25M alone, which represents a 33% increase. Such a crappy Co, potential short.
AXN, AST, AMRN, AMPE are all biotechs that have run up a lot. Potential shorts.
MVIS company just secured a 14M contract to supply components to a "Fortune 100 Company". Potential buy.
REPH, Biotech spiking on product & facility acquisition news, very low float of 860k shares. Potential short but only on perfect setup.
MELA up on some insignificant news about new designated codes, stock ran from 3.20 to 3.60 into the close on no new news. Seems a bit sketchy. Potential short only after it spikes some more as it only has a 20M market cap
CYTX Just did a $40M dilution financing. Co loves diluting shareholders, every year the no of shares outstanding increases. The last 12 months increased by 25M alone, which represents a 33% increase. Such a crappy Co, potential short.
AXN, AST, AMRN, AMPE are all biotechs that have run up a lot. Potential shorts.
Monday, March 16, 2015
Friday, March 13, 2015
Watch List 13-3-15
AXN
Dead pump bounce, spike is holding well. Might get a Friday squeezer.
AMRN
"Analyst" upgraded to $10...BS
Support at 2.35
RMGN
Earnings winner from a few days ago. Potential buy
BONT
Earnings Winner with 4.6M shares short. Could get a nice squeeze. Stock sold off in the second half of the day.
Dead pump bounce, spike is holding well. Might get a Friday squeezer.
AMRN
"Analyst" upgraded to $10...BS
Support at 2.35
RMGN
Earnings winner from a few days ago. Potential buy
BONT
Earnings Winner with 4.6M shares short. Could get a nice squeeze. Stock sold off in the second half of the day.
Thursday, March 12, 2015
Watch List 11-03-15
REPH
Co intends on purchasing a Phase III ready drug and facility for 50M via a loan as well as a 7 year warrant for 350,000 common stock. Lots of resistance at 6.
SYN
Earnings winner, cup and handle pattern forming.
GERN
Earnings were crap, seems like a Zachs pump. Potential short.
AXN
Dead pump bounce, support at 1.2, once cracked the chart will be broken
IFON
Earnings winner with technical support at 2.4.
CRMD
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial adviser. Stock is holding strong, don't short too quickly, note that each wick is higher than each prior wick for the last 7 trading days.
ARQL
Co intends on purchasing a Phase III ready drug and facility for 50M via a loan as well as a 7 year warrant for 350,000 common stock. Lots of resistance at 6.
SYN
Earnings winner, cup and handle pattern forming.
GERN
Earnings were crap, seems like a Zachs pump. Potential short.
AXN
Dead pump bounce, support at 1.2, once cracked the chart will be broken
IFON
Earnings winner with technical support at 2.4.
CRMD
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial adviser. Stock is holding strong, don't short too quickly, note that each wick is higher than each prior wick for the last 7 trading days.
ARQL
Tuesday, March 10, 2015
Watch List 10-3-15
CRMD
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial adviser.
RMGN - RMG Networks Holding Corp.
PR states 30% increase in growth (unaudited financial info), actual earnings released Thursday before market open. 21M market cap, 6M Float (1.5x float rotation day). 12M debt, 5M cash. Stock has been in a downtrend ever since its IPO in 2011. Seems like a buy the rumor sell the news scenario.
STRL
Up on PR stating CEO signed on for another 5 years. This "news" added 12M to their 48M market cap. Earnings conference call on the 16th March. Like to see a bit more spiking to get short.
ARQL
Stock ran into earnings conference, Co reports a loss but price continued to surge. 44M Float, 62M cash, 1.7M debt. No obvious reason for continued run-up, possible reason: shorts got squeezed. MC has increased by 75M since 1.25ish.
REPH
Co intends on purchasing a Phase III ready drug and facility for 50M via a loan as well as a 7 year warrant for 350,000 common stock.
AVEO
Up on Phase II data and analyst upgrade with a target of 3.....BS
IFON
PR Earning winner, earnings out this morning, has news already been priced in? If no morning spike get short on for a fade.
AXN
No news for runup, dead pump bounce, like to see a pop outta the gate to get short into.
ON RADAR
CYTX
Potential buy if it can break the multiday high.
ADXS
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial adviser.
RMGN - RMG Networks Holding Corp.
PR states 30% increase in growth (unaudited financial info), actual earnings released Thursday before market open. 21M market cap, 6M Float (1.5x float rotation day). 12M debt, 5M cash. Stock has been in a downtrend ever since its IPO in 2011. Seems like a buy the rumor sell the news scenario.
STRL
Up on PR stating CEO signed on for another 5 years. This "news" added 12M to their 48M market cap. Earnings conference call on the 16th March. Like to see a bit more spiking to get short.
ARQL
Stock ran into earnings conference, Co reports a loss but price continued to surge. 44M Float, 62M cash, 1.7M debt. No obvious reason for continued run-up, possible reason: shorts got squeezed. MC has increased by 75M since 1.25ish.
REPH
Co intends on purchasing a Phase III ready drug and facility for 50M via a loan as well as a 7 year warrant for 350,000 common stock.
AVEO
Up on Phase II data and analyst upgrade with a target of 3.....BS
IFON
PR Earning winner, earnings out this morning, has news already been priced in? If no morning spike get short on for a fade.
AXN
No news for runup, dead pump bounce, like to see a pop outta the gate to get short into.
ON RADAR
CYTX
Potential buy if it can break the multiday high.
ADXS
Monday, March 9, 2015
Watch List 9-3-15
CRMD - not shortable is ST
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial adviser.
EYES
Co has had its exchange registration revoked...enough said. 14M float, only 1.67M in cash. Co loves promoting through PR's.Wait for confirmed backside of the one.
AXN
No reason for run-up. Possible manipulation
ON RADAR
ADXS
If this keeps spiking is could create a short squeeze out to new highs.
AVEO
Like to see a gap up push and fade, just like the prior 2 days.
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial adviser.
EYES
Co has had its exchange registration revoked...enough said. 14M float, only 1.67M in cash. Co loves promoting through PR's.Wait for confirmed backside of the one.
AXN
No reason for run-up. Possible manipulation
ON RADAR
ADXS
If this keeps spiking is could create a short squeeze out to new highs.
AVEO
Like to see a gap up push and fade, just like the prior 2 days.
Friday, March 6, 2015
Watch List 6-3-15
CAPN - 15M debt, 3.66M cash after Series B warrants. Float: 2.6M
Investors exercised their series B warrant at 6.5 and entered into another warrant (Series C) agreement for 557K shares at and exercises price of 6.25.
AXN - SO:67M, Float:37M, Cash: 1.34M, Debt: 26.15M
Co did a debt conversion in Sept for 11M shares.
GERN
Major resistance at $4
CRMD - MC: 172M, Float: 20M
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial advisor.
EYES - Float: 14M
25M in debt and only 1.67M in cash. Co loves submitting PR's, no SEC filings in 13 years.
HRTX - 16M float
Director/CEO just sold off 10,000 shares (20% of ownership) at 13.07 the day before he presented at a conference, he must have soo much confidence in the Co. Company is making huge losses 70M over the last year. Co has 86M in the bank, but I'm guessing it from the IPO. Given the rate they're burning through cash, Co will most likely need to do a financing in the next year to stay afloat.
Investors exercised their series B warrant at 6.5 and entered into another warrant (Series C) agreement for 557K shares at and exercises price of 6.25.
AXN - SO:67M, Float:37M, Cash: 1.34M, Debt: 26.15M
Co did a debt conversion in Sept for 11M shares.
GERN
Major resistance at $4
CRMD - MC: 172M, Float: 20M
Company has just extended the expiry on existing warrants till April 30. Co has also entered into a backstop loan agreement with a current investor for 4.5M will can be accessed at anytime before April 30. Co also just released the lamest PR regarding their new financial advisor.
EYES - Float: 14M
25M in debt and only 1.67M in cash. Co loves submitting PR's, no SEC filings in 13 years.
HRTX - 16M float
Director/CEO just sold off 10,000 shares (20% of ownership) at 13.07 the day before he presented at a conference, he must have soo much confidence in the Co. Company is making huge losses 70M over the last year. Co has 86M in the bank, but I'm guessing it from the IPO. Given the rate they're burning through cash, Co will most likely need to do a financing in the next year to stay afloat.
Thursday, March 5, 2015
Watch List 5-3-15
OREX - Price is putting in lower highs over the last 2 days. Keep an eye on trend forming. Stock trapped shorts today before cracking in the arvo.
IFON - 10M Float, 36M market cap, like to see a push outta the get to get short.
CAPN - Mega low float--> 2M, Market cap: 59M. Numbers don't add up. 16M debt, 64K in the bank. Shit company.
SECONDARY WATCHES
AVEO - 80M market cap, 46M float
NVGN - 8M float, 33M Market cap.
CRMD - Stock is slowly trending. Not ideal.
IFON - 10M Float, 36M market cap, like to see a push outta the get to get short.
CAPN - Mega low float--> 2M, Market cap: 59M. Numbers don't add up. 16M debt, 64K in the bank. Shit company.
SECONDARY WATCHES
AVEO - 80M market cap, 46M float
NVGN - 8M float, 33M Market cap.
CRMD - Stock is slowly trending. Not ideal.
Tuesday, March 3, 2015
WatchList 3-3-15
ONCY - 98M
Biotech stock up on numerous PR's. Stock is nearing major resistance/bagholder area of 1.25.
JOB - 32M
Another shitty company, delisting play.
TCON - 210M
Recent IPO, initial authorized shares were 10M, now that they've incoporated in Delaware theyv'e reauthorized 200M. This opens the door for endless dilution.
XIN - 252M
Sketchy Chinese company cannot validate anything. Tonnes of overhead resistance
CRMD - 126M
1.75M shares expire on the 24th March at an exercise price of 3.4375 making this run-up from 1.5 seem a little suss.
Biotech stock up on numerous PR's. Stock is nearing major resistance/bagholder area of 1.25.
JOB - 32M
Another shitty company, delisting play.
TCON - 210M
Recent IPO, initial authorized shares were 10M, now that they've incoporated in Delaware theyv'e reauthorized 200M. This opens the door for endless dilution.
XIN - 252M
Sketchy Chinese company cannot validate anything. Tonnes of overhead resistance
CRMD - 126M
1.75M shares expire on the 24th March at an exercise price of 3.4375 making this run-up from 1.5 seem a little suss.
Subscribe to:
Posts (Atom)